Sep 30, 2024
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
Dec 08, 2020
Piramal Pharma Solutions Invests ~$32 Million to Expand its Riverview Michigan Facility for Additional Capacity in Potent and Non-Potent API Development and Manufacturing
Aug 27, 2020
Piramal Pharma Solutions to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs
Jun 20, 2020
Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.
Dec 03, 2019
Piramal Pharma Solutions Announces Collaboration With BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment
Jun 20, 2019
Piramal Pharma Solutions Invests $10 Million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.
Jun 18, 2019
Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle
Nov 20, 2018
Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai
Oct 17, 2018
Piramal Pharma Solutions Recognized as 'Industry Partner of the Year' at the Global Generics & Biosimilars Awards 2018
Oct 05, 2018
Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions(TM)
Mar 27, 2018
Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'
Nov 07, 2017
Piramal Pharma Solutions Wins 'Industry Partner of the Year' at the Global Generics & Biosimilars Awards 2017
Oct 25, 2017
Piramal Pharma Solutions Wins at Prestigious CPhI Pharma Awards
Oct 09, 2017
Piramal Pharma Solutions Announces Large-scale Expansion of API Manufacturing Facilities
Sep 07, 2017
Piramal Pharma Solutions Names John Fowler as its Chief Operating Officer